$42.4B
$38,000
0.01% of portfolio
430
Q4 2020
New
$46.3B
$40,000
0.01% of portfolio
608
Q3 2024
Reduced 5.44%
$7.96B
$28,000
0.01% of portfolio
728
Q2 2024
Reduced 46.59%
$113B
$38,000
0.01% of portfolio
133
Q2 2024
Reduced 0.75%
$27.3B
$41,000
0.01% of portfolio
498
Q3 2023
Added 100.0%
$4.82B
$38,000
0.01% of portfolio
696
Q3 2024
Added 1.02%
$0
$31,000
0.01% of portfolio
1,678
Q4 2020
New
$101B
$48,000
0.01% of portfolio
623
Q3 2024
Reduced 13.83%
$27.8B
$29,000
0.01% of portfolio
1,431
Q3 2024
Reduced 18.88%
$0
$28,000
0.01% of portfolio
106
Q2 2022
Reduced 18.46%
$60.8B
$53,000
0.01% of portfolio
300
Q3 2024
Added 33.33%
$4.48B
$42,000
0.01% of portfolio
900
Q2 2024
Reduced 18.18%
$0
$55,000
0.01% of portfolio
544
Q2 2022
Reduced 50.0%
$0
$34,000
0.01% of portfolio
591
Q2 2024
Added 2.25%
$138B
$48,000
0.01% of portfolio
133
Q2 2024
Reduced 0.75%
$77.9B
$55,000
0.01% of portfolio
300
Q2 2022
Reduced 2.28%
$0
$29,000
0.01% of portfolio
415
Q2 2024
Added 0.24%
$49.5B
$31,000
0.01% of portfolio
97
Q2 2024
Reduced 3.96%
$44.7B
$62,000
0.01% of portfolio
1,089
Q3 2024
Reduced 36.24%
$30.7B
$45,000
0.01% of portfolio
420
Q3 2024
New
$19.1B
$37,000
0.01% of portfolio
550
Q2 2024
Added 22.22%
$0
$26,000
0.01% of portfolio
239
Q3 2024
Added 3.91%
$31B
$39,000
0.01% of portfolio
355
Q3 2024
Added 0.57%
$7.95B
$46,000
0.01% of portfolio
641
Q3 2024
Reduced 12.43%
$96.5B
$41,000
0.01% of portfolio
814
Q3 2024
Added 1.24%
$145B
$60,000
0.01% of portfolio
939
Q3 2024
Added 0.54%
$0
$51,000
0.01% of portfolio
1,000
Q4 2020
New
$0
$58,000
0.01% of portfolio
726
Q3 2024
Added 0.28%
$0
$39,000
0.01% of portfolio
566
Q3 2024
Added 0.71%
$0
$54,000
0.01% of portfolio
303
Q4 2023
Added 51.5%
$47.3B
$32,000
0.01% of portfolio
232
Q3 2024
Added 0.43%
$62.7B
$32,000
0.01% of portfolio
450
Q3 2024
Added 0.9%
$0
$59,000
0.01% of portfolio
1,143
Q2 2024
Added 5.83%
$71.8B
$42,000
0.01% of portfolio
155
Q2 2024
Reduced 10.4%
$77.8B
$67,000
0.01% of portfolio
241
Q3 2024
Added 25.52%
$0
$38,000
0.01% of portfolio
800
Q4 2020
New
$0
$32,000
0.01% of portfolio
332
Q2 2024
Reduced 44.39%
Ncr Atleos Corporation Com Shs
-
$0
0.0% of portfolio
-
Q1 2024
New
$20.3B
$13,000
0.0% of portfolio
83
Q2 2024
Reduced 70.77%
$185B
$7,000
0.0% of portfolio
15
Q3 2024
Added 400.0%
$0
$12,000
0.0% of portfolio
660
Q3 2024
Added 2.33%
Outlook Therapeutics Inc Com
-
$0
0.0% of portfolio
-
Q1 2024
New
$0
$20,000
0.0% of portfolio
613
Q3 2024
Reduced 35.06%
$0
$8,000
0.0% of portfolio
204
Q3 2024
New
Ft Vest U.S. Small Cap Moderate Buffer ETF November
-
$0
0.0% of portfolio
-
Q1 2024
New
$3.31B
$3,000
0.0% of portfolio
111
Q4 2020
New
$0
$17,000
0.0% of portfolio
1,250
Q4 2020
New
$108B
$18,000
0.0% of portfolio
203
Q2 2024
Reduced 1.46%
$0
$0
0.0% of portfolio
2,842
Q3 2024
Added 0.21%
$17.5B
$8,000
0.0% of portfolio
30
Q3 2021
New